In the most optimistic scenario, the use of GLP-1 agonists could lead to what we call virtue spirals. In these spirals, weight loss could lead to: Increased physical activity Healthier food choices Sustained weight management This positive feedback loop could influence more than just diet and exercise
Common GLP-1 meds include: Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro, Zepbound) Liraglutide (Saxenda, Victoza) Dulaglutide (Trulicity) When comparing Mounjaro vs
Normally, repair crews (blood vessels, fibroblasts, macrophages etc) take time to arrive and fix the damage especially in low-traffic areas like tendons and ligaments that dont get much blood flow
Standardizing your rotation schedule and injection technique can significantly reduce week-to-week variability in how you feel
Polarization profiles of human M-CSF-generated macrophages and comparison of M1-markers in classically activated macrophages from GM-CSF and M-CSF origin
On the other hand, IV delivery skips digestion entirely, allowing for maximum absorption and immediate availability